Date closed: 5/16/2016

Value: US$24.6 million

On May 16, 2016, Zenith Epigenetics Corp. announced that it closed a private placement of 24,560,500 common shares at a price of US$1.00 per share for gross proceeds of US$24,560,500 to Eastern Capital Limited. The shares are subject to a four month hold period.

Zenith Epigenetics Corp., headquartered in Calgary, Alberta is a biotechnology firm.

BLG represented Zenith Epigenetics Corp. by Lloyd McLellan.